Their poorer neurological status can be related to the complicated medical course from severe COVID-19 (i.e., ARDS requiring anti-IL-6 therapy), acute cardiac dysfunction (10), fatal ICH, and iatrogenic from heavy sedation, ventilator, and ECMO therapies. This evidence concerns the gene IL6 and acute respiratory distress syndrome.